Page last updated: 2024-08-24

lisofylline and Diabetes Mellitus, Adult-Onset

lisofylline has been researched along with Diabetes Mellitus, Adult-Onset in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Braman, V; Cheng, C; Dao, M; Graham, P; Liu, J; Neutel, J; Sabounjian, L; Shipley, J; Wu, L	1

Trials

1 trial(s) available for lisofylline and Diabetes Mellitus, Adult-Onset

Article	Year
A First-in-Patient, Multicenter, Double-Blind, 2-Arm, Placebo-Controlled, Randomized Safety and Tolerability Study of a Novel Oral Drug Candidate, CTP-499, in Chronic Kidney Disease. Clinical pharmacology in drug development, 2016, Volume: 5, Issue:4 Topics: Administration, Oral; Aged; Aged, 80 and over; Biomarkers; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Pentoxifylline; Phosphodiesterase Inhibitors; Renal Insufficiency, Chronic; Tablets	2016

Article

Year

A First-in-Patient, Multicenter, Double-Blind, 2-Arm, Placebo-Controlled, Randomized Safety and Tolerability Study of a Novel Oral Drug Candidate, CTP-499, in Chronic Kidney Disease.

Clinical pharmacology in drug development, 2016, Volume: 5, Issue:4

Topics: Administration, Oral; Aged; Aged, 80 and over; Biomarkers; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Pentoxifylline; Phosphodiesterase Inhibitors; Renal Insufficiency, Chronic; Tablets

2016